1 Sommers SC, Murphy SA, Warren S: Pancreatic duct hyperplasia and cancer. Gastroenterology 1954;27:629-640.
2 Zalatnai A: Pancreatic cancer - a continuing challenge in oncology. Pathol Oncol Res 2003;9:252-263.
3 Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonen-docrine pancreas cancer. Cancer Res 1976;36:2690-2698.
4 Kozuka S, Sassa R, Taki T, et al: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 1979;43:1418-1428.
5 Tada M, Ohashi M, Shiratori Y, et al: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227-231.
6 Suda K, Mogaki M, Oyama T: A comparison between hyperplasia of ductal epithelium and mucin producing tumor of the pancreas. Rinsho Byori 1991;39:1220-1224.
7 Klimstra DS, Longnecker DS: K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 1994;145:1547-1548.
8 Ohhashi K, Murakami Y, Yakekoshi T: Four cases of 'mucinous producing' cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982;20:348-351.
9 Hruban RH, Takaori K, Klimstra DS, et al: An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987.
10 Hruban RH, Adsay NV Albores-Saavedra J, et al: Pancreatic intraepithelial neoplasia (PanIN): a New nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
11 Longnecker DS, Adler G, Hruban RH, Kloppel G: Intraductal papillary-mucinous neoplasms of the pancreas; in WHO Classification of Tumors of the Digestive System. 2000, pp 237-240.
12 Kim YS, Gum J Jr, Brockhausen I: Mucin glycoproteins in neoplasia. Glycoconj J 1996;13: 693-707.
13 Kim YS, Gum JR Jr, Crawley SC, et al: Mucin gene and antigen expression in biliopancreatic carcinogenesis. Ann Oncol 1999;10:S51-S55.
14 Itzkowitz S, Kjeldsen T, Friera A, et al: Expression of Tn, Sialyosyl Tn, and T antigens in human pancreas. Gastroenterology 1991;100:1691-1700.
15 Williams SJ, Wreschner DH, Tran M, et al: MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001;276:18327-18336.
16 Hendrix H, Hewetson A, Mansharamani M, et al: Oviduct (MUC9) is expressed in rabbit endo-cervix. Endocrinology 2001;142:2151-2154.
17 Melnick M, Chen H, Zhou Y, et al: An alternatively spliced Muc 10 glycoprotein ligand for putative L-selectin binding during mouse embryonic submandibular gland morphogenesis. Arch Oral Biol 2001;46:745-757.
18 Williams SJ, McGuckin MA, Gotley DC, et al: Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59:4083-4089.
19 Adsay NV, Merati K, Andea A, et al: The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15:1087-1095.
20 Nakamura A, Horinouchi M, Goto M, et al: New classification of pancreatic intraductal papillary-mucinous tumor by mucin expression: its relationship with potential for malignancy. J Pathol 2002;197:201-210.
21 Adsay NV, Merati K, Nassar H, et al: Pathogenesis of colloid (pure-mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003;27:571-578.
22 Luttges J, Schlehe B, Menke MA, et al: The K-ras mutation pattern in pancreatic ductal adenocar-cinoma usually is identical to that in associated normal, hyperplastic and metaplastic ductal epithelium. Cancer 1999;85:1703-1710.
23 Luttges J, Diederichs A, Menke MA, et al: Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer 2000;88:2495-2504.
24 Kloppel G, Bommer G, Ruckert K, et al: Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch A Pathol Anat Histol 1980;387:221-233.
25 Matsubayashi H, Watanabe H, Nishikura K, et al: Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation. Cancer 1998;82:651-660.
26 Terhune PG, Phifer DM, Tosteson TD, et al: K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 1998;7:515-521.
27 Lemoine NR, Jain S, Hughes CM, et al: Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992:102:230-236.
28 Terada T, Ohta T, Kitamura Y, et al: Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study. Arch Pathol Lab Med 1998;122:42-46.
29 Abe K, Suda K, Arakawa A, et al: Different pattern of p16 and p53 protein expression in intraduc-tal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas; in print.
Keiko Abe, MD
Department of Human Pathology, Juntendo University School of Medicine 2-1-1 Hongo, Bunkyo-ku Tokyo 113-8421 (Japan)
Tel. +81 3 5802 1037, Fax +81 3 3812 1056, E-Mail [email protected]
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.